CIENCIASMEDICASNEWS: Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests G Zhu et al, Pharmacogenomics Journal, September 2021

domingo, 5 de septiembre de 2021

Impact of genetic variation in CYP2C19, CYP2D6, and CYP3A4 on oxycodone and its metabolites in a large database of clinical urine drug tests G Zhu et al, Pharmacogenomics Journal, September 2021

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)